+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality; End User, and Country- Product Image
Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality; End User, and Country- Product Image
Sale

Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality; End User, and Country

  • PDF Icon

    Report

  • 181 Pages
  • September 2022
  • Region: Europe
  • The Insight Partners
  • ID: 5006367
UP TO OFF until Dec 31st 2024
Description Jump to:
The colorectal cancer market in Europe is expected to grow from US$ 4,627.82 million in 2022 to US$ 5,819.96 million by 2028; it is estimated to grow at a CAGR of 2.9% from 2022 to 2028.

The market for colorectal cancer is ascribed to frequent diagnostic tests and new drug launches. Many major market players are involved in manufacturing a wide range of drugs and diagnostic tests that help in reducing the burden of colorectal cancer. For instance, in June 2021, Bristol Myers Squibb announced the approval of Opdivo plus Yervoy by the European Commission (EC) for the treatment of adult patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer. Also, in September 2019, Lupin, an Indian pharmaceutical company, partnered with Boehringer Ingelheim, a German-based pharmaceutical company, for the development of cancer drugs. The companies collaborated to develop and commercialize a drug based on the MEK inhibitor. The molecule is likely to target specific cancer cells and treat patients suffering from stomach and skin cancer. In June 2019, Pfizer, Inc. launched ZIRABEV, a biosimilar to Avastin that helps in the treatment of five cancers, including colorectal cancer. Thus, the constant developments and new product launches in colorectal cancer diagnostics and therapeutics are driving the colorectal cancer market growth in Europe.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe colorectal cancer market at a substantial CAGR during the forecast period.

Europe Colorectal Cancer Market Segmentation

The Europe colorectal cancer market is segmented into modality, end user, and country.
  • Based on modality, the Europe colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment held the largest market share and is expected to register the highest CAGR during the forecast period.
  • Based on end user, the Europe colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment held a larger market share.
  • Based on country, the Europe colorectal cancer market is segmented into France, Germany, Italy, Spain, the UK, and the Rest of Europe. The Rest of Europe held the largest market share in 2022.
Abbott, Amgen Inc., Bruker Corporation, EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies operating in the Europe colorectal cancer market.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Colorectal Cancer Market - By Modality
1.3.2 Europe Colorectal Cancer Market - By End User
1.3.3 Europe Colorectal Cancer Market - By Country
2. Europe Colorectal Cancer Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Colorectal Cancer- Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Europe Colorectal Cancer Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 New Product Launches
5.1.3 Benefits Offered by Generic Drugs
5.2 Market Restraints
5.2.1 Pricing Pressure on Drug Manufacturers
5.3 Future Trends
5.3.1 Shift Toward Personalized Medicine
5.4 Impact Analysis
6. Europe Colorectal Cancer Market- Europe Analysis
6.1 Europe Colorectal Cancer Market Revenue Forecast and Analysis
7. Europe Colorectal Cancer Market Analysis - By Modality
7.1 Overview
7.2 Europe Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
7.3 Diagnosis Type
7.3.1 Overview
7.3.2 Diagnosis Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 Immunohistochemistry
7.3.3.1 Overview
7.3.3.2 Immunohistochemistry: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Stool Test
7.3.4.1 Overview
7.3.4.2 Stool Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.5 Flexible Sigmoidoscopy
7.3.5.1 Overview
7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.6 Colonoscopy
7.3.6.1 Overview
7.3.6.2 Colonoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.7 CEA Test
7.3.7.1 Overview
7.3.7.2 CEA Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.8 Other Test
7.3.8.1 Overview
7.3.8.2 Other Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Therapy Type
7.4.1 Overview
7.4.2 Europe Therapy Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3 Chemotherapy
7.4.3.1 Overview
7.4.3.2 Chemotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3.3 Alkylating Agent
7.4.3.3.1 Overview
7.4.3.3.2 Alkylating Agent: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3.4 Antimetabolites
7.4.3.4.1 Antimetabolites: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3.5 Others
7.4.3.5.1 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4 Immunotherapy
7.4.4.1 Overview
7.4.4.2 Immunotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.3 Panitumumab
7.4.4.3.1 Overview
7.4.4.3.2 Panitumumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.4 Cetuximab
7.4.4.4.1 Overview
7.4.4.4.2 Cetuximab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.5 Bevacizumab
7.4.4.5.1 Overview
7.4.4.5.2 Bevacizumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.6 Others
7.4.4.6.1 Overview
7.4.4.6.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.5 Chemoprotectant
7.4.5.1 Overview
7.4.5.2 Chemoprotectant: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging Type
7.5.1 Overview
7.5.2 Europe Imaging Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5.3 Computed Tomography (CT)
7.5.3.1 Overview
7.5.3.2 Computed Tomography (CT) : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5.4 Magnetic Resonance Imaging (MRI)
7.5.4.1 Overview
7.5.4.2 Magnetic Resonance Imaging (MRI) : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others
7.5.5.1 Overview
7.5.5.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe Colorectal Cancer Market Revenue and Forecast To 2028 - By End User
8.1 Overview
8.2 Europe Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic and Research Laboratories
8.4.1 Overview
8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe Colorectal Cancer Market Revenue and Forecast to 2028 - Country Analysis
9.1 Overview
9.1.1 Europe: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
9.1.1.1 Germany: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Germany: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.2 Germany: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.1.2.1 Germany: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.1.1.2.2 Germany: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.1.1.2.2.1 Germany: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
9.1.1.1.2.2.2 Germany: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.1.1.2.3 Germany: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.1.1.3 Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.2 France: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 France: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.2 France: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.2.2.1 France: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.1.2.2.2 France: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.1.2.2.2.1 France: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
9.1.1.2.2.2.2 France: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.1.2.2.3 France: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.1.2.3 France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.3 UK: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 UK: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.2 UK: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.3.2.1 UK: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.1.3.2.2 UK: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.1.3.2.2.1 UK: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
9.1.1.3.2.2.2 UK: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.1.3.2.3 UK: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.1.3.3 UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.4 Italy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.1 Italy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.2 Italy: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.4.2.1 Italy: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.1.4.2.2 Italy: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.1.4.2.2.1 Italy: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
9.1.1.4.2.2.2 Italy: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.1.4.2.3 Italy: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.1.4.3 Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.5 Spain: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.1 Spain: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.2 Spain: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.5.2.1 Spain: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.1.5.2.2 Spain: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.1.5.2.2.1 Spain: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
9.1.1.5.2.2.2 Spain: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.1.5.2.2 Spain: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.1.5.3 Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.6 Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.1 Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.2 Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.6.2.1 Rest of Europe: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.1.6.2.2 Rest of Europe: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.1.6.2.2.1 Rest of Europe: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
9.1.1.6.2.2.2 Rest of Europe: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.1.6.2.3 Rest of Europe: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.1.6.3 Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
10. Global Colorectal Cancer Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.4 Inorganic Developments
10.4.1 Overview
10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028
11. Company Profiles
11.1 Epigenomics AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Novigenix SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Amgen Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 F. HOFFMANN-LA ROCHE LTD.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Bruker Corporation
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Quest Diagnostics Incorporated
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 EDP Biotech Corporation
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Volitionrx Limited
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms

Companies Mentioned

  • Abbott
  • Amgen Inc.
  • Bruker Corporation
  • Clinical Genomics Technologies Pty Ltd.
  • Epigenomics AG
  • F. Hoffmann-La Roche AG
  • Quest Diagnostics
  • VolitionRx Limited

Table Information

Report AttributeDetails
No. of Pages181
PublishedSeptember 2022
Forecast Period2022 - 2028
Estimated Market Value ( USD ) in 2022 $ 4627.82 Million
Forecasted Market Value ( USD ) by 2028 $ 5819.96 Million
Compound Annual Growth Rate2.9%
Regions CoveredEurope
No. of Companies Mentioned8

Related Topics

Related Reports

Colorectal Cancer Drugs Global Market Report 2024 - Product Image

Colorectal Cancer Drugs Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Colorectal Cancer Drugs Market by Drug Class, Treatment Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Colorectal Cancer Drugs Market by Drug Class, Treatment Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Colorectal Cancer Screening & Diagnostic Market by Product Type, Age Group, End-use - Global Forecast 2025-2030 - Product Image

Colorectal Cancer Screening & Diagnostic Market by Product Type, Age Group, End-use - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Microsatellite Stable Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.